At Wall Street Journal, Government-Enforced Monopolies = ‘Free Market’ By Dean Baker

Those folks at the Wall Street Journal are really turning reality on its head. Today it ran a column by Robert Ingram, a former CEO of Glaxo Wellcome, complaining about efforts to pass “transparency” legislation in Massachusetts, New York and a number of other states. This legislation would require drug companies to report their profits on certain expensive drugs, as well as government funding …

GlaxoSmithKline_Logo

GlaxoSmithKline’s Corporate Rap Sheet – Philip Mattera

London-based GlaxoSmithKline is the product of the 2000 merger of two drug giants: Glaxo—which had its origins in the infant formula business and then jumped to the top ranks of the pharmaceutical industry on the basis of the extraordinarily popular ulcer drug Zantac—and SmithKline Beecham, which was itself the product of a merger of a U.S. and a British drugmaker …